CBDS — Cannabis Sativa Income Statement
0.000.00%
Last trade - 00:00
- $1.07m
- $2.71m
- $1.17m
- 47
- 44
- 15
- 27
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.16 | 1.94 | 1.84 | 1.56 | 1.17 |
Cost of Revenue | |||||
Gross Profit | 0.697 | 1.2 | 1.14 | 0.961 | 0.773 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.96 | 3.73 | 3.58 | 2.96 | 2.28 |
Operating Profit | -3.81 | -1.79 | -1.74 | -1.4 | -1.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.01 | -1.71 | -2.35 | -1.26 | -1.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.01 | -1.71 | -2.35 | -1.26 | -1.32 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.94 | -2.17 | -2.45 | -1.22 | -1.39 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.94 | -2.17 | -2.45 | -1.22 | -1.39 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.118 | -0.056 | -0.081 | -0.032 | -0.021 |